Advertisement

Transgenic Mice Expressing IFN-γ in the Epidermis Are a Model of Inflammatory Skin Disease and Systemic Lupus Erythematosus

  • F. M. Watt
Conference paper
Part of the Ernst Schering Research Foundation Workshop book series (SCHERING FOUND, volume 50)

Keywords

Systemic Lupus Erythematosus Lupus Nephritis Contact Dermatitis Autoantibody Production Cutaneous Lupus Erythematosus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arata J, Abe-Matsuura Y (1994) Generalized vitiligo preceded by a generalized figurate erythematosquamous eruption. J Dermatol 21:438–441PubMedGoogle Scholar
  2. Barker JN, Mitra RS, Griffiths CE, Dixit VM, Nickoloff BJ (1991) Keratinocytes as initiators of inflammation. Lancet 337:211–214PubMedCrossRefGoogle Scholar
  3. Berden JH (1997) Lupus nephritis. Kidney Int 52:538–558PubMedCrossRefGoogle Scholar
  4. Burlingame RW, Rubin RL, Balderas RS, Theofilopoulos AN (1993) Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest 91:1687–1696PubMedCrossRefGoogle Scholar
  5. Carroll JM, Crompton T, Seery JP, Watt FM (1997) Transgenic mice expressing IFN-γ in the epidermis have eczema, hair hypopigmentation, and hair loss. J Invest Dermatol 108:412–422PubMedCrossRefGoogle Scholar
  6. Casciola-Rosen L, Rosen A (1997) Ultraviolet light-induced keratinocyte apoptosis: a potential mechanism for the induction of skin lesions and autoantibody production in LE. Lupus 6:175–180PubMedCrossRefGoogle Scholar
  7. David-Bajar KM, Davis BM (1997) Pathology, immunopathology, and immunohistochemistry in cutaneous lupus erythematosus. Lupus 6:145–157PubMedCrossRefGoogle Scholar
  8. Desai-Mehta A, Mao C, Rajagopalan S, Robinson T, Datta SK (1995) Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus. J Clin Invest 95:531–541PubMedCrossRefGoogle Scholar
  9. Dustin ML, Singer KH, Tuck DT, Springer TA (1988) Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon gamma and is mediated by intercellular adhesion molecule 1 (ICAM-1). J Exp Med 167:1323–1340PubMedCrossRefGoogle Scholar
  10. Enk AH, Katz SI (1995) Contact sensitivity as a model for T-cell activation in skin. J Invest Dermatol 105:80S–83SPubMedCrossRefGoogle Scholar
  11. Griffiths CE, Voorhees JJ, Nickoloff BJ (1989) Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol 20:617–629PubMedCrossRefGoogle Scholar
  12. Gu D, Wogensen L, Calcutt NA, Xia C, Zhu S, Merlie JP, Fox HS, Lindstrom J, Powell HC, Sarvetnick N (1995) Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction. J Exp Med 181:547–557PubMedCrossRefGoogle Scholar
  13. Hertle MD, Kubler MD, Leigh IM, Watt FM (1992) Aberrant integrin expression during epidermal wound healing and in psoriatic epidermis. J Clin Invest 89:1892–1901PubMedCrossRefGoogle Scholar
  14. Kondo S, McKenzie RC, Sauder DN (1994) Interleukin-10 inhibits the elicitation phase of allergic contact hypersensitivity. J Invest Dermatol 103: 811–814PubMedCrossRefGoogle Scholar
  15. Korb LC, Ahearn JM (1997) Clq binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol 158:4525–4528PubMedGoogle Scholar
  16. Kotzin BL (1996) Systemic lupus erythematosus. Cell 85:303–306PubMedCrossRefGoogle Scholar
  17. Lee MS, von Herrath M, Reiser H, Oldstone MB, Sarvetnick N (1995) Sensitization to self (virus) antigen by in situ expression of murine interferon-gamma. J Clin Invest 95:486–492PubMedCrossRefGoogle Scholar
  18. Lever WF, Lever GS (1983) Connective tissue diseases. In: Lever WF, Lever GS (eds) Histopathology of the skin. J.B. Lippincott, Philadelphia, PA, pp 445–471Google Scholar
  19. McGowan KM, Coulombe PA (1998) Onset of keratin 17 expression coincides with the definition of major epithelial lineages during skin development. J Cell Biol 143:469–486PubMedCrossRefGoogle Scholar
  20. Metcalfe A, Streuli C (1997) Epithelial apoptosis. Bioessays 19:711–720PubMedCrossRefGoogle Scholar
  21. Mevorach D, Zhou JL, Song X, Elkon KB (1998) Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 188: 387–392PubMedCrossRefGoogle Scholar
  22. Norris DA (1993) Pathomechanisms of photosensitive lupus erythematosus. J Invest Dermatol 100:58S–68SPubMedCrossRefGoogle Scholar
  23. Peng SL, Madaio MP, Hayday AC, Craft J (1996) Propagation and regulation of systemic autoimmunity by γδ T cells. J Immunol 157:5689–5698.PubMedGoogle Scholar
  24. Radic MZ, Weigert M (1994) Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol 12:487–520PubMedCrossRefGoogle Scholar
  25. Saulnier M, Huang S, Aguet M, Ryffel B (1995) Role of interferon-gamma in contact hypersensitivity assessed in interferon-gamma receptor-deficient mice. Toxicology 102:301–312PubMedCrossRefGoogle Scholar
  26. Schon MP (1999) Animal models of psoriasis — what can we learn from them? J Invest Dermatol 112:405–410PubMedCrossRefGoogle Scholar
  27. Schultz RM, Kleinschmidt WJ (1983) Functional identity between murine gamma interferon and macrophage activating factor. Nature 305:239–240PubMedCrossRefGoogle Scholar
  28. Seery JP, Carroll JM, Cattell V, Watt FM (1997) Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon γ in the epidermis. J Exp Med 186:1451–1459PubMedCrossRefGoogle Scholar
  29. Seery JP, Cattell V, Watt FM (2001) Cutting edge: amelioration of kidney disease in a transgenic mouse model of lupus nephritis by administration of the caspase inhibitor carbobenzoxy-valyl-alanyl-aspartyl-(beta-o-methyl)-fluoromethylketone. J Immunol. 167:2452–2455PubMedGoogle Scholar
  30. Seery JP, Wang EC, Cattell V, Carroll JM, Owen MJ, Watt FM (1999) A central role for αβ T cells in the pathogenesis of murine lupus. J Immunol 162:7241–7248PubMedGoogle Scholar
  31. Takahashi H, Kobayashi H, Hashimoto Y, Matsuo S, Iizuka H (1995) Interferon-gamma-dependent stimulation of Fas antigen in SV40-transformed human keratinocytes: modulation of the apoptotic process by protein kinase C. J Invest Dermatol 105:810–815PubMedCrossRefGoogle Scholar
  32. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969–976PubMedCrossRefGoogle Scholar
  33. von den Driesch P, Fartasch M, Hornstein OP (1992) Chronic actinic dermatitis with vitiligo-like depigmentation. Clin Exp Dermatol 17:38–43PubMedCrossRefGoogle Scholar
  34. Weil M, Raff MC, Braga VM (1999) Caspase activation in the terminal differentiation of human epidermal keratinocytes. Curr Biol 9:361–364PubMedCrossRefGoogle Scholar
  35. White S, Rosen A (2003) Apoptosis in systemic lupus erythematosus. Curr Opin Rheumatol 15:557–562PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • F. M. Watt
    • 1
  1. 1.Imperial Cancer Research FundLondonUK

Personalised recommendations